ITGR

$87.21

Post-MarketAs of Mar 17, 8:00 PM UTC

Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$87.21
Potential Downside
36.3%
Whystock Fair Value$55.55
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Devices

Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structura...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$3.06B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
30.18
Beta
Defensive asset. Lower volatility than the S&P 500.
0.74
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
6.11%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
2.05

Recent News

Insider Monkey
Mar 17, 2026

Artisan Small Cap Fund Sold Integer Holdings (ITGR) as Thesis Did Not Materialize

Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Small Cap Fund”. A copy of the letter can be downloaded here. The Fund seeks to invest in companies that possess franchise characteristics, with strong earnings trajectories, and are trading at a discount to the estimated private market value. Despite strong results […]

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Mar 14, 2026

A Look At Integer Holdings (ITGR) Valuation After Governance Changes And Activist Cooperation

Integer Holdings (ITGR) is back in focus after a cooperation agreement with activist investor Irenic Capital Management added two independent directors to the board, reshaping governance and sharpening attention on shareholder priorities. See our latest analysis for Integer Holdings. At a share price of US$82.98, Integer Holdings has seen a 14.1% 90 day share price return and an 8.1% year to date share price return. The 1 year total shareholder return of a 29.6% decline contrasts with a 13.7%...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Insider Monkey
Mar 6, 2026

Integer Holdings Corp (ITGR) Was Down 40% YOY Despite Strong Market Position and a Competitive Moat

13D Activist Fund is a mutual fund that focuses on companies that are targeted by shareholder activists. The Fund released its Q4 2025 investor letter. A copy of the letter can be downloaded here. In Q4 2025, the I share (DDDIX) returned 0.40%, net of fees and expenses, versus 2.19% for the Russell 2000 Index. YTD, the […]

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Feb 27, 2026

3 Small-Cap Stocks We Keep Off Our Radar

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.

BEARISH
Negative press. News cycle fixated on risk factors or misses.
StockStory
Feb 26, 2026

5 Must-Read Analyst Questions From Integer Holdings’s Q4 Earnings Call

Integer Holdings saw a positive market reaction to its fourth quarter results, as revenue and non-GAAP earnings per share both exceeded Wall Street expectations. Management cited strong performance in the Cardio & Vascular segment, particularly from acquisitions and demand in neurovascular, as a primary driver. CEO Peyman Khales emphasized the role of operational improvements and disciplined expense management, noting, "Operational improvements accounted for $30 million, or $0.86 per share, and

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.